Working... Menu

Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme (SEJ)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03047473
Recruitment Status : Recruiting
First Posted : February 9, 2017
Last Update Posted : February 6, 2019
Information provided by (Responsible Party):
Dr. Francois Jacques, Clinique Neuro-Outaouais

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : September 2019
  Estimated Study Completion Date : March 2020